Furthermore, upregulating KRAS and MEK-ERK in ovarian cancer cells could stabilize spheroid formation; in this form, it has advantages in promoting survival and metastasis than single cells, and tumor-associated macrophages also involved in spheroid formation, by promoting binding of cancer cells and activating EGFR signaling pathways [21,22]. This evidence concerns the gene EGFR and cancer.